Back to search

Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections

Data up to Jan 2025

Published1997
Citations862
References100

Total Citations Per Year

Abstract

References (100)

Biostatistical Analysis (2nd ed.).

1986 • 5,963 citations

A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia

1994 • 1,040 citations

Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989

1991 • 896 citations

Resistance of Candida species to fluconazole

1995 • 890 citations

Fluconazole

1990 • 658 citations

Antibacterial susceptibility tests : Dilution and disk diffusion methods.

1995 • 553 citations

Multicenter evaluation of four methods of yeast inoculum preparation

1988 • 462 citations

Resistance of Candida albicans biofilms to antifungal agents in vitro

1995 • 404 citations

The Clinical Pharmacokinetics of Itraconazole: An Overview

1989 • 381 citations

Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans

1985 • 362 citations

Role of pharmacokinetics in the outcome of infections

1988 • 354 citations

Antifungal susceptibility testing

1993 • 351 citations

Epidemiology of oral candidiasis in HIV-infected patients: Colonization, infection, treatment, and emergence of fluconazole resistance

1994 • 321 citations

Treatment of Refractory Disseminated Nontuberculous Mycobacterial Infection With Interferon Gamma: A Preliminary Report

1994 • 297 citations

Pharmacokinetics of itraconazole following oral administration to normal volunteers

1988 • 285 citations

Resistance of Candida albicans to Fluconazole During Treatment of Oropharyngeal Candidiasis in a Patient with AIDS: Documentation by In Vitro Susceptibility Testing and DNA Subtype Analysis

1994 • 271 citations

Listeria monocytogenes in Nature

1971 • 259 citations

Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests

1992 • 250 citations

Fluconazole resistance in Candida glabrata

1993 • 246 citations

Pharmacokinetic profile of orally administered itraconazole in human skin

1988 • 243 citations

Emerging fungal pathogens

1989 • 211 citations

Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis

1994 • 205 citations

Detection of amphotericin B-resistant Candida isolates in a broth-based system

1995 • 202 citations

Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates

1995 • 200 citations

Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts

1993 • 197 citations

Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus

1994 • 194 citations

Collaborative investigation of variables in susceptibility testing of yeasts

1990 • 193 citations

Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo

1986 • 185 citations

Interaction of Azoles with Rifampin, Phenytoin, and Carbamazepine: In Vitro and Clinical Observations

1992 • 181 citations

Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome

1996 • 168 citations

Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates

1994 • 161 citations

Opportunistic Candidiasis: An Epidemic of the 1980s

1995 • 160 citations

Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing

1995 • 158 citations

Fluconazole-Resistant Candida albicans

1993 • 154 citations

High-dose itraconazole in the treatment of severe mycoses

1991 • 151 citations

Susceptibility testing of Cryptococcus neoformans: a microdilution technique

1992 • 151 citations

Identification of Patients with Acute AIDS-Associated Cryptococcal Meningitis Who Can Be Effectively Treated with Fluconazole: The Role of Antifungal Susceptibility Testing

1996 • 140 citations

Use of amphotericin B with azole antifungal drugs: what are we doing?

1995 • 139 citations

Effect of protein binding of daptomycin on MIC and antibacterial activity

1991 • 134 citations

Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine

1995 • 130 citations

In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin

1992 • 125 citations

Interaction of Ketoconazole with Rifampin and Isoniazid

1984 • 123 citations

Correlation between In Vitro and In Vivo Activity of Antifungal Agents against Candida Species

1994 • 120 citations

Safety and pharmacokinetics of fluconazole in children with neoplastic diseases

1992 • 119 citations

Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods

1987 • 118 citations

Comparison study of broth macrodilution and microdilution antifungal susceptibility tests

1991 • 115 citations

Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole

1994 • 112 citations

Azole resistance in Candida albicans.

1986 • 97 citations

Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography

1993 • 96 citations

The pharmacokinetics of itraconazole in animals and man: an overview

1987 • 93 citations

Ketoconazole therapy of progressive coccidioidomycosis

1988 • 92 citations

Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia

1992 • 92 citations

Use of a colorimetric system for yeast susceptibility testing

1995 • 92 citations

In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus

1994 • 90 citations

Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B

1986 • 84 citations

Fluconazole resistance in Candida in patients with AIDS—A therapeutic approach

1993 • 82 citations

Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients

1995 • 78 citations

Susceptibility testing of fungi: current status of the standardization process

1993 • 74 citations

Variations in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis

1995 • 72 citations

Simple method for detecting fluconazole-resistant yeasts with chromogenic agar

1996 • 71 citations

Correlation of In Vitro Azole Susceptibility with In Vivo Response in a Murine Model of Cryptococcal Meningitis

1993 • 71 citations

Antimycotic efficacy of bifonazole in vitro and in vivo.

1983 • 69 citations

Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium

1992 • 69 citations

Effect of protein binding on serum bactericidal activities of ceftazidime and cefoperazone in healthy volunteers

1988 • 66 citations

Fluconazole-resistant Candida in AIDS patients

1993 • 65 citations

Etest for antifungal susceptibility testing of yeasts

1994 • 60 citations

DNA Subtypes and Fluconazole Susceptibilities of Candida albicans Isolates from the Oral Cavities of Patients with AIDS

1995 • 60 citations

Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis

1992 • 57 citations

Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus

1994 • 53 citations

Quality control guidelines for National Committee for Clinical Laboratory Standards--recommended broth macrodilution testing of ketoconazole and itraconazole

1996 • 49 citations

Experience with Itraconazole in Deep Mycoses in Northern Italy. Erfahrungen mit Itraconazol bei tieflokalisierten Mykosen in Norditalien

1987 • 47 citations

Strain variation among and antifungal susceptibilities of isolates of Candida krusei

1996 • 45 citations

Steady State Parenteral Kinetics of Fluconazole in Man

1988 • 42 citations

Collaborative evaluation in seven laboratories of a standardized micromethod for yeast susceptibility testing

1988 • 42 citations

In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp

1995 • 41 citations

European standards for antibiotic susceptibility testing: Towards a theoretical consensus

1990 • 39 citations

Ketoconazole and fluconazole drug interactions.

1993 • 39 citations

In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method

1995 • 36 citations

Sublethal Concentrations of Antibiotics, Effects on Bacteria and the Immune System

1982 • 36 citations

Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain

1995 • 36 citations

Clinical Aspects of Tetanus

1989 • 35 citations

Collaborative investigation of broth microdilution and semisolid agar dilution for in vitro susceptibility testing of Candida albicans

1992 • 34 citations

Activity of fluconazole: postantifungal effect, effects of low concentrations and of pretreatment on the susceptibility of Candida albicans to leucocytes

1994 • 31 citations

Is there a correlation between serum antifungal drug concentration and clinical outcome?

1994 • 30 citations

Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model

1996 • 29 citations

pH and other effects on the antifungal activity of cilofungin (LY121019)

1989 • 29 citations

Teicoplanin and daptomycin bactericidal activities in the presence of albumin or serum under controlled conditions of pH and ionized calcium

1993 • 29 citations

Effects of Sub‐Inhibitory Concentrations of Antifungal Agents on Adherence of Candida spp. to Buccal Epithelial Cells in Vitro: Die Wirkung subinhibitorischer Antimyzetika‐Konzentrationen auf die Adharenz von Candida‐Arten an Epithelzellen der Mundschleimhaut

1989 • 28 citations

The relevance of pharmacokinetics to in-vitro models: protein binding--does it matter?

1985 • 25 citations

Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata

1994 • 24 citations

Human serum enhances the postantibiotic effect of fluoroquinolones against Staphylococcus aureus

1991 • 23 citations

Molecular karyotyping of multiple yeast species isolated from nine patients with AIDS during prolonged fluconazole therapy

1996 • 21 citations

In vivo interaction of ketoconazole and sucralfate in healthy volunteers

1994 • 21 citations

[Multicenter study of the standardization of sensitivity testing of fungi to 5-fluorocytosine and amphotericin B].

1987 • 18 citations

ARTs versns ASTs: where are we going?

1991 • 17 citations

DNA macrorestriction profiles and antifungal susceptibility of Candida (Torulopsis) glabrata

1996 • 17 citations

Antimicrobial Susceptibility Tests: Testing Methods and Interpretive Problems

1994 • 16 citations

Dirithromycin disc susceptibility tests: interpretative criteria and quality control parameters

1993 • 10 citations

Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test medium

1992 • 7 citations

Preliminary interpretive susceptibility testing criteria for FK-037 with 30-microgram disks

1994 • 3 citations

Cited By (0)

Loading...